NCT02014688

Brief Summary

This study is being initiated to create a normal database including measures of optic nerve head (ONH), peripapillary retinal nerve fiber layer (RNFL), and macula using the Heidelberg Spectralis OCT device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
166

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

December 11, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 18, 2013

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
Last Updated

August 20, 2015

Status Verified

August 1, 2015

Enrollment Period

9 months

First QC Date

December 11, 2013

Last Update Submit

August 19, 2015

Conditions

Keywords

Normal subjects

Outcome Measures

Primary Outcomes (1)

  • Normative Data for optic nerve head, the peripapillary retinal nerve fiber layer, and the macula.

    This normal database will be used to determine if an unknown subject has measurement values "within normal limits" or "outside normal limits." It is planned to classify an eye "within normal limits" if the measurement value is greater than or equal to the 5th percentile of the normal distribution (or less than or equal to the 95th percentile), and as "outside normal limits" if the measurement value is smaller than the 1st percentile (or larger than 99th percentile) of the normal distribution. Thus, the sample size must be large enough to ensure that the 1st and the 5th percentiles of the distribution are distinct.

    12 months

Study Arms (4)

American Indian or Alaskan Native Descent

Black or African American Descent

Asian Descent

Hispanic Descent

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Recruitment will be from persons who respond to recruitment initiatives at the individual centers or have signed a release saying that they are willing to be approached for participation in research. At least 87 subjects (enrollment target: 135 subjects) will be selected from qualifying normal volunteers. Age range will be from ≥18 to 90 years. The age of the subjects will be defined by their month of birth versus the month of giving consent to participate in this study. A subject who is 40 years and 11 months old will be counted as being in the age group "31 to 40 years". Each site will attempt to recruit subjects in about equal numbers in each age group. The distribution in the age groups should be fairly equal among subjects in each ethnic group alone.

You may qualify if:

  • Subject is not an employee of the eye clinic.
  • Age ≥18 to 90.
  • Able and willing to undergo the test procedures, give consent, and to follow instructions.
  • Healthy eye without prior intraocular surgery (except cataract surgery) and without clinically significant vitreal, retinal or choroidal diseases, clinically significant diabetic retinopathy (subject may have diabetes), or disease of the optic nerve. Small Drusen are acceptable in older subjects.
  • Hispanic Descent, Black or African American Descent, Asian Descent, American Indian or Alaskan Native Descent
  • Negative history of glaucoma.
  • Intraocular pressure ≤21mmHg.
  • Best corrected visual acuity ≥0.5.
  • Refraction between +6 and -6 diopters and astigmatism ≤ 2 diopters.
  • Normal visual field with Glaucoma Hemifield Test and Mean Deviation within normal limits, or not abnormal visual field by judgment of the ophthalmologist.
  • Clinically normal appearance of the optic disc, with normal appearing neuroretinal rim with respect to color and shape. The optic disc is examined ophthalmoscopically and by evaluation of stereo photographs.
  • When both eyes are eligible, both eyes enter the study.

You may not qualify if:

  • Unreliable visual field. The reliability indices should be used as guide as well as the perimetrist's notes.
  • Unusable disc stereo photos.
  • Inability to undergo the tests.
  • Insufficient quality of Spectralis OCT images (this is not determined until after Spectralis OCT examination, and is an unusual circumstance). Minimum requirements are:
  • Retina completely included in image frame,
  • Quality Score ≥ 20 in the stored ART mean images, and
  • For ONH-R scan: Center position error ≤ 100 μm.
  • Note: Inability of a subject to perform one of the two scan patterns or insufficient image quality in one scan pattern does not exclude the subject or eye from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York Eye and Ear Infirmary

New York, New York, 10003-4297, United States

Location

Study Officials

  • Jeffrey Liebman, MD

    Manhattan Eye, Ear and Throat Hospital and New York University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2013

First Posted

December 18, 2013

Study Start

December 1, 2013

Primary Completion

September 1, 2014

Study Completion

October 1, 2014

Last Updated

August 20, 2015

Record last verified: 2015-08

Locations